Meridian Co., Ltd. (OTC:BB MRDAF) - 500 Beiträge pro Seite

[cyba]

Meridian Signs a US $27 Million Dollar Letter of Intent for Exclusive Distribution Rights to Lapex 2000 LipoLaser in the United Kingdom and South Africa
Tuesday April 24, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Apr 24, 2007 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that it has signed a letter of intent with England-based Bal-Sal Distribution LLC ("Bal-Sal") for the granting of exclusive marketing and distribution rights to Meridian's Lapex 2000 LipoLaser in the United Kingdom (England, Wales, Scotland and Northern Ireland) and South Africa.

The letter of intent sets out the material terms to be included in a definitive contract to be entered into by Meridian and Bal-Sal. The material terms include exclusive marketing and distribution rights during the term of the contract and minimum purchase order commitments of $6.75 million USD during the first year of the contract, $13.5 million USD during the first two years of the contract and $27 million USD during the full three year term of the contract. Bal-Sar intends to market and distribute the Lapex 2000 LipoLaser through its UK affiliate Skin Revision (UK) Ltd. and its South African affiliate Skin Revision (Pty) Ltd.

The parties anticipate executing a definitive contract by May 15, 2007.

"We at Meridian are very excited about the potential represented by this opportunity for revenue growth and product exposure outside the customary markets for Meridian devices," commented Mr. Hyeon Seong Myeong, President of Meridian.

More About: Lapex 2000 LipoLaser

The Lapex 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The Lapex 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but non-clinical settings such as spas and wellness centers that treat localized body fat deposits which may not have responded to diet and exercise.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received approvals from the FDA and other international regulatory agencies, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

More About: Skin Revision

Skin Revision UK Ltd.

Office: +44 - 2073292000

Fax: +44 - 2072480668

Tracey Nathan (Director)

[e-mail]

John Malherbe (Director)

[e-mail]

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.


Contact:

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: http://www.MeridianMedical.ca


Source: Meridian Co., Ltd.

[cyba]

Meridian Co., Ltd.: LAPEX 2000 LipoLaser Clinical Study Exceeds Expectations
Thursday May 17, 6:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--May 17, 2007 -- Meridian Co., Ltd. ("Meridian") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that it has just completed its double-blind clinical research study under the investigation of Dr. Frank Greenway and Dr. T.S. Guillot, at LSU School of Human Ecology in Louisiana.

The study explored the efficacy of the LAPEX 2000 LipoLaser in body contouring and fat reduction on subjects' waistlines as evidence by girth measurements and photographs. The study concluded that within the study population the LAPEX 2000 LipoLaser provided a significant girth loss that was maintained over repeated treatments that were cumulative over the entire duration of the study.

"The improvement in appearance was evident both clinically and statistically" reports Dr. Frank Greenway, the primary investigator for the study and Medical Director and Professor at the Biomedical Research Centre at the Louisiana State University in Baton Rouge.

Meridian President Hyeon-Seong Myeong commented "we are excited that the study exceeded our objectives in both girth measurements and that there are visible improvements in the photographs."

Source: Meridian Co., Ltd.

[cyba]

Meridian Signs Contract for Exclusive Distribution of the LAPEX 2000 LipoLaser in Taiwan
Thursday May 24, 7:10 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--May 24, 2007 -- Meridian Co., Ltd. ("Meridian") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that it has signed a contract with Oliver Co., Ltd. ("Oliver") for exclusive marketing and distribution of Meridian's LAPEX 2000 LipoLaser in Taiwan.

The contract outlines that Oliver will be granted an exclusive license to market the LAPEX 2000 LipoLaser in Taiwan. Their exclusive distributorship for the LAPEX 2000 LipoLaser is based on a minimum order volume equal to sales of approximately US$750,000 for the initial 12-month period of the agreement. Under the terms of the agreement, Oliver has pre-paid US$100,000 to Meridian for the first portion of the initial purchase order.

Oliver is a Taiwanese medical equipment importer that distributes obesity management related products and equipment.

Source: Meridian Co., Ltd.

[cyba]

Antwort auf Beitrag Nr.: 29.451.897 von cyba am 24.05.07 15:28:59

jetzt kann es losgehen

minimum $750.000,00 - $100.000,00 hamwa schon im sack

und das ist erst eine von mehreren PR's die lt. IR in den nächsten wochen wahrscheinlich veröffentlicht werden!!

[cyba]

Lunch hour lipo?
Posted May 21st 2007 9:31AM by Anne Metz

Liposuction used to be considered a major cosmetic treatment involving anesthesia, recovery time and a lengthy healing process. Thanks to a nifty machine called Smartlipo, a slimmer physique can be had in about 20 minutes. Known also as laser lipolysis, Smartlipo uses a non-invasive lipo light to melt away inches.



After applying a local anesthetic, the physician makes a tiny incision into the fat layer where he or she then inserts the lipo light. Heat from the laser is dispersed in wave-like patterns to melt the fat cells. Melted fat is then released into the bloodstream where it is processed by the liver, and finally expunged by the body as waste material.

Another significant between Smartlipo and traditional liposuction is that the Smartlipo laser actually seals of blood vessels as it goes so that patients face minimal post-op pain. Smartlipo also costs roughly the same amount as conventional liposuction even though the procedure is simpler and faster. But like they say, no pain no gain.

http://www.styledash.com/2007/05/21/lunch-hour-lipo/

[cyba]

Lipo in your lunch hour
From The Sunday Times
May 20, 2007

Spend 20 minutes having your fat lasered now, and you could be a bikini size smaller by August. Sound too good to be true? Sally Brown investigates the new non-invasive body-shaping procedures

No cosmetic treatment has a bigger word-of-mouth buzz right now than Smartlipo. Also known as laser lipolysis, this non-invasive, “liposuction lite” technique sounded almost too good to be true when it was launched in the UK late last year. Six months on, the first women to have the procedure are seeing the full results, which have been difficult to judge until now.

“I’ve gone from a size 12 to a size 10 in jeans since I had Smartlipo on my tummy,” says Shalini Mistry, 29, who arranged her treatment through Botonics (www.botonics.co.uk). “It took 20 minutes, it was was completely painless and I went out for lunch afterwards.”

Women who would never consider liposuction are queuing up for Smartlipo, even though, at £2,000-£4,000, it’s not much cheaper than the full op. “I think television makeover programmes that show liposuction have put a lot of women off, because it looks an aggressive, traumatic procedure. You can see the surgeon really pushing the canula around with some force,” says Dr Patrick Bowler, author of The Nervous Girl’s Guide to Nip&Tuck (Harper Thorsons £7.99) and medical director of Court House Clinics. “Smartlipo is much, much gentler. It doesn’t require a general anaesthetic, and there are no stitches.”

Another big part of its appeal is the quick recovery time. “I dropped the children off at school, went to the clinic, had Smartlipo, then picked the children up at 3.30pm, and nobody except my husband had any idea I’d had anything done,” says Olivia Carrol, 34, an accountant from Portsmouth, who had treatment on her stomach, love handles and chin six weeks ago at the Snowberry Lane Clinic, in Wiltshire (www.snowberrylane.co.uk). “With three kids, I simply couldn’t be out of action for three weeks, which I’ve heard is how long it takes to recover from liposuction. I was a bit sore the next day, but, to be honest, the most painful part of the whole procedure was the local-anaesthetic injection.”

Because the canula used in the procedure is ultra-fine and flexible and no vacuum suction is performed, the trauma to the body is light. The incision made in the skin is so tiny, it doesn’t even need stitching. After a local-anaesthetic injection, the laser is inserted into the layer of fat just underneath the skin and moved around in slow, fanning movements. The heat it produces destroys the walls of the fat cells and liquefies the fat within them, while sealing off blood vessels, which minimises internal bleeding and bruising. Depending on the number of areas treated, the procedure can take from 20 minutes to two and a half hours.

The melted fat is released into the bloodstream and then removed and metabolised by the liver like any other fat. To ensure the liver isn’t overloaded, the total amount of fat treated at one time is limited to 500ml, and the technique isn’t advisable for anyone with liver problems, but you don’t need to stick to a low-fat diet or avoid alcohol afterwards. The gradual processing of the fat can take up to 12 weeks, and while that means the results aren’t instant, it does mean they’re easy to pass off as the result of dieting. When the full effect is achieved, it’s permanent.

“The fat cells in the area are either destroyed or damaged, and, as the majority of people don’t make new fat cells after puberty (if you put on weight, the cells get bigger), it’s highly unlikely they’ll come back,” says Dr Mike Comins, who offers Smartlipo at his Hans Place Practice, in Knightsbridge (www.hansplace.com). A bonus effect is firmer skin – the heat of the laser stimulates the skin’s fibroblasts to produce collagen, leaving skin tighter and smoother-looking.

It took four months to see the full effects of the Smartlipo that Sam Taylor, a 29-year-old events co-ordinator, had on her saddlebag thighs, at Comins’s clinic. “I had the treatment in October last year and started to really notice the difference in January; by February, my thighs were a completely different shape,” she says. “The effect is smooth and natural – there are no lumps. I’ve always eaten a healthy diet and I exercise at the gym at least four times a week, but every woman in my family has the same saddlebags. I wanted rid of them, but I have a low pain threshold and I’m too wimpy even to consider liposuction. The Smartlipo took 20 minutes, and, while it felt a bit weird, it didn’t hurt, and I went shopping at Harvey Nichols afterwards.”

If you want an immediate improvement, Dr Rupert Gabriel of the Snowberry Lane Clinic offers the option of having a small amount of fat “aspirated”, or sucked out, during the procedure. “It’s not simply a case of adding liposuction at the end,” Gabriel says. “We use a much finer canula and lower vacuum pressure, because we’re removing lasered, not solid, fat. The recovery time is the same as for the usual Smartlipo procedure.”

Smartlipo received FDA approval in the USA in November last year and met European CE safety standards at about the same time. So far, it has an impressive safety record. “All procedures have a degree of operator dependency, but the good thing about Smartlipo is that it’s very hard to do harm with it,” Gabriel says. “The main possible side effect is infection, but the risk is tiny, and patients are given a three-day course of antibiotics to minimise it further.” It’s a doctor-only procedure, and, to date, about 20 have been trained in the UK. “As with all aesthetic techniques, those who do it most tend to be best at it, so ask your doctor how many people they’ve treated,” Gabriel says. “A good clinic should show you before-and-after pictures and even allow you to talk to previous patients, if requested.”

The most popular areas for treatment are the inner and outer thighs, love handles, bingo wings, podgy knees and post-baby jelly belly. It’s also a good alternative to a tummy tuck for eliminating the dreaded caesarean overhang – the bulge of flab that hangs over a caesarean scar and refuses to budge, no matter how much weight you lose.

But Smartlipo does have its limitations. The ideal patient is slim and toned, with a localised area of stubborn fat they’d like to remove. It’s not an alternative to dieting if you have a lot of weight to lose. “I wouldn’t recommend Smartlipo for anyone with a BMI (body-mass index) of more than 25,” Gabriel says. But if you are in good shape and would like to hit the beach without your saddlebags or love handles this year, it could be the treatment for you.

FAT-ZAPPERS FOR NEEDLE-PHOBES

If you like the idea of Smartlipo, but are too squeamish even for a local anaesthetic, the following techniques produce similar results and are completely needle-free. The downside is they’re more time-consuming.

UltraShape Shrinks flabby bits by up to 6cm by breaking down fat cells with ultrasound in three one-hour sessions, a month apart. “Most patients say the treatment is relaxing, and you can go to the gym, go to work or go shopping afterwards,” says the aesthetic surgeon Barbara Jemec. From £2,450 to £3,400 at London Bridge Plastic Surgery (www.lbps.co.uk)

Accent Uses radiofrequency to break down fat in several half-hour sessions. “The effect is more subtle than SmartLipo, but it’s also cheaper. Five treatments can result in 5cm loss,” says Dr Patrick Bowler. £1,080 for a course of six, from Court House Clinics (www.courthouseclinics.co.uk)

Smartlipo costs from £2,000, for one area, to about £4,000, if three areas are treated at once. To find a clinic that offers it, go to www.consultingroom.com

http://www.timesonline.co.uk/tol/life_and_style/health/artic…

[cyba]

Meridian Signs Contract for Exclusive Distribution of the LAPEX 2000 LipoLaser for the South Eastern United States
Monday June 11, 12:23 pm ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jun 11, 2007 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that its North American distributor, Meridian Medical Inc. ("MMI") has signed an exclusive contract with Lifeline Medical Technology, LLC ("LifeLine")for the marketing and sales of Meridian's LAPEX 2000 LipoLaser

The contract outlines that LifeLine will be granted an exclusive license to market the LAPEX 2000 LipoLaser in the states of Florida and Georgia. Their exclusive distributorship for the LAPEX 2000 LipoLaser is based on a minimum order volume equal to sales of approximately US $2.3 million for the initial 12-month period of the agreement.

"With an experienced management team, and an aggressive marketing plan we are very excited about launching this product to medical facilities and wellness spas," says Chris Male, president of LifeLine.

More About: LAPEX 2000 LipoLaser

The LAPEX 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The LAPEX 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but in any clinical setting such as spas and wellness centers that treat localized body fat deposits which may not have responded to diet and exercise.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

More About: LifeLine Medical Technology, LLC

LifeLine Medical Technology is an affiliate of the PMG Group of Companies that began in 1997 to own and operate renal care centers in the southeastern US. Recently, they have evolved to include health and wellness products in its service line. LifeLine Medical Technology, LLC may be reached at [e-mail].

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.


Contact:

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: http://www.meridianmedical.ca


Source: Meridian Co., Ltd.

[cyba]

Meridian Signs $27 Million Contract and Received Deposit for First Order
Tuesday June 12, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jun 12, 2007 -- Meridian Co., Ltd. ("Meridian") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that it has signed a contract and has received a deposit of US $100,000 for the initial purchase order of the LAPEX 2000 LipoLaser from Bal-Sar Distribution LLC ("Bal-Sar").

"Bal-Sar" and "Meridian" agreed to an exclusive distribution contract for both the United Kingdom and South Africa under the affiliate SKIN REVISION (PTY) Ltd. Skin Revisions has committed to firm orders that equate to over $27 million over the next 3 years. Skin Revision is thrilled about launching the product in both the UK and South African markets this summer.

More About: LAPEX 2000 LipoLaser

The LAPEX 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The LAPEX 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but also in any clinical setting such as spas and wellness centers that treat localized body fat deposits.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in North America, Asia, Europe, and Africa and continues to successfully market its superior product line to a growing number of clients worldwide.

More About: Skin Revisions

The company Skin Revision was founded seventeen years ago by Tracey Nathan who saw the need to provide skin care products that would reverse the signs of damage and aging of the skin and body. Tracey has never ceased in her endeavours to bring to Southern Africa, and now to the United Kingdom for the first time, a wide range of the most advanced cosmetology equipment, the latest breakthroughs in aesthetic medicine, the newest generation of professional, natural cosmetics, cosmeceuticals and nutriceuticals. Skin Revisions may be reached at [e-mail].

On Behalf of the Board of Directors, Hyeon Seong Myeong President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Source: Meridian Co., Ltd.

[cyba]

Meridian Signs Medical Endorsement Contract With Dr. Lionel Bissoon, a Prominent Celebrity Weight-Loss Doctor in the USA
Tuesday June 19, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jun 19, 2007 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is thrilled to have Dr. Lionel Bissoon, a prominent celebrity weight-loss doctor, contract with the company to become the exclusive medical endorser for the LAPEX 2000 LipoLaser . This innovative new medical device is currently pending an FDA 510(k) clearance in the United States.

Dr. Bissoon is the leading authority in the U.S.A. on Mesotherapy (medical specialty focusing on promoting weight loss and eliminating cellulite) with practices in New York and Palm Beach. Dr. Bissoon is the best selling author of The Cellulite Cure and has been featured in numerous print and broadcast stories including appearances on ABC's "20/20", The Rachael Ray Show, CBS's "48 Hours", Vogue, People, and the New York Times.

Dr. Bissoon will work with Meridian regarding potential speaking or representation engagements at trade shows or medical conferences where he will discuss product information pertaining to the LAPEX 2000 LipoLaser. Dr. Bissoon is very excited about this new technology and commented, "The LAPEX 2000 LipoLaser holds the potential to revolutionize the aesthetic market for the reduction of cellulite and will offer clients a fantastic new non-invasive alternative to help them meet their goals."

Source: Meridian Co., Ltd.

[ANNALENTZ]

Antwort auf Beitrag Nr.: 28.971.998 von cyba am 24.04.07 15:33:44

JANUARY 2007, Medixsysteme, FRANCE, NIMES, Innovative Medical Aesthetic SMES, who already operates in the field of precise electronic injection, comforts its leading position on the Medical Aesthetic market with its Dual Aesthetic therapeutic ultrasound for surgery clinics to propose novel combined focalised therapeutic ultrasounds for patients in lipotherapy or body contouring.

ULTRACONTOUR© is unique and patented at INPI (French Industrial property office), it is first device in the world to offers double ultrasound options to physician :

· Manual programme with a focalised hand piece transducer HIFU
· Automatic programme with sequential chains of transducers UMD

ULTRACONTOUR© is totally non invasive treatment combined HIFU transducers and patented multisequential ultrasounds waves© to treat directly the fat cells and drain the fluids and the waste immediately after in the lymphatic system.

WHY USING A FOCALISED – THERAPEUTICALLY COMBINATION
One treatment phase to mechanically and thermally stimulate fat cells elimination at focal area, a real fat exfoliation.
A second phase to stimulate elimination by draining ultrasound massage UMD© and drug activity mediation of active ingredient gel.

HOW ULTRACONTOUR OPERATES ?
ULTRACONTOUR HAS SELECTED THE LATEST TECHNOLOGY IN THERAPEUTIC HIFU TRANSDUCERS FOR OPTIMAL RESULTS IN BODY SHAPING

HIFU have proven and experienced application in therapeuty protocols of traditional medical application by imminent physicians all over the world on three continents.

Ultracontour generates high power acoustic waves that are precisely localised and precisely controlled in amplitude,

Guarantees an improved degree of reliability and safety taking into account the use of a larger amount of electrical and acoustical energy.

IS IT SAFE TO USE ULTRACONTOUR ?
Totally in line with previous devices implementation, the Firm Medixsysteme operates and developped Ultracontour under ISO 9001 –13845 certification – Annex 5 of Directive relative to Medical Device . Ultracontour is CE Medical marked.

USA development is the next steps for ULTRACONTOUR, who has already selected several physicians for the FDA clearance in five different US States, Plastic Surgeons and Dermatologists.
Medixsysteme is now dealing with several partnerships proposals of US based companies to develop this large and promising market where a third of the population about 60 millions are overweight.

MEDIXSYSTEME is an international SMEs that always has a step ahead in medical aesthetic innovation.
Based in South of France, the company has a scientific committee and collaborate with Medical university in south Europe

MEDIXSYSTEME
51 rue Laennec
30900 NIMES
France
Tel [phone]
Fax[phone]
Email : [e-mail]
Website : www.ultracontour.fr
Contact : Laetitia, Ms, Export Dept.

[cyba]

Meridian Co. Receives CE Mark Approval for its Aesthetic Laser
Thursday July 19, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jul 19, 2007 -- Meridian Co., Ltd. ("the Company") (OTC BB:MRDAF.OB - News) today announced its European notified body has granted CE Mark approval for the Company's LAPEX Laser Body Contouring System (LAPEX BCS). This approval will allow the Company to begin marketing the LAPEX BCS in the European Union (EU) and other countries around the world that recognize the CE Mark approval.

The CE Mark certifies that the product has met EU health, safety and environmental requirements that ensure consumer and workplace safety.

To the Company's knowledge, the LAPEX BCS is the only low level laser device available that can provide total inch loss in a non-invasive manner. Meridian currently has potential distributors ready to begin an aggressive marketing and sales campaign in the UK, Germany, Spain, Austria, Switzerland, Italy, and South Africa.

Commenting on this CE Mark approval, Meridian Co. President, Mr. Myeong said, "We are excited to be able to provide this valuable service to consumers and to further develop our global presence."

Source: Meridian Co., Ltd.

[cyba]

[cyba]

schöner support bei $1.50

[cyba]

!

Dieser Beitrag wurde moderiert.

[cyba]

!

Dieser Beitrag wurde moderiert.

[cyba]

Meridian Signs US$3.5 Million Sales Contract with Enterone Co.
Wednesday August 29, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Aug 29, 2007 -- Meridian Co., Ltd. (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that it has signed a contract with Enterone Co., Ltd. ("Enterone") for exclusive marketing and distribution of Meridian's Digital Pulse Analyzer (DPA) in Korea.

Their exclusive distributorship for the DPA is based on a minimum order volume equal to sales of approximately US$3.5 million over the next 3 years. Under the terms of the agreement, Enterone has pre-paid 300,000,000 Korean Won (approximately US$320,000) to Meridian for the first portion of the initial purchase order.

The initial marketing focus of Enterone will be the growing health and wellness industry within Korea, specifically wellness and anti-aging clinics. Enterone is expanding its marketing efforts into the rapidly growing medical device industry. Executives at Enterone believe the unique line of Meridian's non-invasive health care devices is perfectly paired to capture a share of today's expanding wellness market.

More About: Enterone Co., Ltd.

Enterone is a KOSDAQ (Korean stock market similar to NASDAQ) listed company trading under the code 035500. Established in 1993, Enterone has been conducting media production and distribution and resort and tourism business. With its distribution experience, existing networks, and marketing and media production expertise, Enterone has exciting plans to aggressively launch the DPA within the growing health and wellness industry.

More About: Digital Pulse Analyzer ("DPA")

The DPA accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA-cleared and Health Canada approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

Cardiovascular disease is the number one killer of both men and women in the United States with an estimated economic cost of approximately $298 billion. The Company feels that use of the DPA can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

By continuing its commitment for the globalization and advancement of integrative medical products, Meridian seeks to transform health care from a focus on disease to a focus on wellness and prevention. By working towards this vision, Meridian can ensure it becomes a world-class company for its customers and could ultimately decrease the financial burden placed on the existing, expensive, allopathic health care industry.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Source: Meridian Co., Ltd.

[cyba]

Meridian's DPA Receives "Korean World-Class Product Award"
Wednesday September 19, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Sep 19, 2007 -- As further evidence that the wellness industry owns one of the most innovative product segments within the global economy, Meridian Co., Ltd. (OTC BB:MRDAF.OB - News) ("Meridian" or the "Company") has been awarded a "Korean World-Class Product Award" for its Digital Pulse Analyzer (DPA) which measures the elasticity and estimated real age of human arteries with just a touch of a finger.

The award was recently presented to Meridian's founder, Hyeon Seong Myeong, by Korea's Minister of Commerce, Industry and Energy on behalf of the award sponsor, the Korea Industrial Technology Foundation (KOTEF).

"On behalf of everyone at Meridian, we are so pleased that the KOTEF has recognized the DPA as a World-Class product," said Myeong. "With products that focus on prevention of disease like the DPA and its component Heart Rate Variability software, medical professionals and wellness practitioners around the world now have a painless, simple and easily portable means to accurately measure their clients' risk for cardiovascular disease."

Two hundred products were initially selected from various industrial sectors based on recommendations by several Korean business associations. After an initial review, 75 products were selected for a third screen which yielded 27 products worthy of the World Class Award. Products from the major Korean manufacturers were also included. LG Electronics' high-definition disk player and SK's Lithium Ion Battery Separator (LIBS) were also selected.

As a KOTEF's awarded company, Meridian is qualified to participate in the World-Class Product Tradeshow and receive other forms of marketing support from the KOTEF. KOTEF sponsors the Korean World-Class Product Award competition every year to advocate innovative practices among industry technology innovators.

More About: KOTEF

KOTEF is an organization established to develop and promote industrial technology by establishing the industry, academy, institution cooperative system and expanding the industrial technology base. For more information about KOTEF please visit http://english.kotef.or.kr/.

More About: Digital Pulse Analyzer ("DPA")

The DPA accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA-cleared and Health Canada approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

Cardiovascular disease is the number one killer of both men and women in the United States with an estimated economic cost of approximately $298 billion. The Company feels that use of the DPA can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry.

Source: Meridian Co., Ltd.

[cyba]

Clinical Study Revealing Girth Reduction with Non-invasive Laser to be Presented at the NAASO Meeting
Thursday October 18, 1:39 pm ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Oct 18, 2007 -- Meridian Co., Ltd. (OTC BB:MRDAF.OB - News) -

Results from a Louisiana State University study in which the LAPEX 2000 LipoLaser was used to reduce girth around study participants' waistlines is scheduled to be presented at the North American Association for the Study of Obesity (NAASO) Annual Scientific Meeting, Oct. 20, in New Orleans. Study leaders will reveal that within the study group the new LAPEX 2000 LipoLaser, manufactured by Meridian Co., Ltd., provided "significant girth loss that is sustained over repeated treatments". The forty study participants (both men and women between the ages of 18 and 65) experienced an average girth loss of one inch over the course of the study.

"We sincerely appreciate all the efforts of Dr. Frank Greenway and the entire study team at LSU for their efforts to prove the LAPEX 2000 LipoLaser is effective for its intended use," said Anna Brazier, President of Meridian Medical, Inc., the exclusive North American distributor for the LipoLaser. "This study was a significant part of our FDA submission for body contouring and girth reduction indications which, to our knowledge, will be the first laser in the entire aesthetics industry for this 100% non-invasive modality."

Brazier is currently awaiting a response from the FDA regarding a submission for the two new aesthetic indications. The LAPEX 2000 has already received clearance for sale and use in the United States for general hand and wrist pain associated with Carpal Tunnel Syndrome.

"Due to the uniqueness of our claims regarding how the device reduces fat within the body, we needed to address additional questions. We feel we have successfully fulfilled that obligation," said Brazier. "Based on our very recent CE clearance, which allows us to market the device for body contouring and girth reduction throughout the entire European Union, combined with our submission to FDA, we look forward to updating all our stakeholders with favorable information in the near future."

In related news, Meridian is currently reviewing proposals for the distribution of the LAPEX 2000 LipoLaser in France, Turkey, Dubai and Mexico.

The Company has hired Jay Hopkins, a sales and marketing professional with several years of experience in the aesthetics industry, to oversee the North American launch of the LAPEX 2000 LipoLaser once the new indications are approved. Most recently, Hopkins sold Class IV laser equipment from Iridex and Laserscope to the dermatology and plastic surgery market. Hopkins plans to conduct LipoLaser sales and marketing out of his Seattle, Washington-based offices.

Source: Meridian Co., Ltd.

[cyba]

Antwort auf Beitrag Nr.: 32.092.804 von cyba am 20.10.07 12:21:13

combined with our submission to FDA, we look forward to updating all our stakeholders with favorable information in the near future.

[cyba]

New at Healing What Is: no pain fat shrinkage!

Introducing LipoLaser, a revolutionary medical device for spot fat reduction and the treatment of cellulite!

A safe, painless and completely non-invasive treatment program for body contouring, LipoLaser uses the medical technology of Low Level Laser (LLL) and shows superior results over any other existing non-invasive methods.

LLL was first medically used for pain relief, skin regeneration and cell activation following surgery or other wounds. A clinical trial using a slightly different frequency demonstrated that it was effective for fat reduction and continuing studies show that LLL is safe and effective for this purpose.

LipoLaser works by focusing the cold red laser into the fat cells where the fat (LDL the "bad" cholesterol) is extracted through the cellular wall and is then liquefied into the intercellular area. The liquefied fat drains through the body's lymph system (which is responsible for removing wastes from the body) resulting in increased LDL in the blood and urine. The effectiveness of fat drainage during and after treatment is dependent on optimal functioning of the lymphatic system The treatment is particularly effective for hard-to-reduce trouble spots, such as love handles, tummy bulge and saddlebags. Results can be quite significant within a few treatments. In fact, many people are able to see measurable results after only one treatment.

The K2 program

The LipoLaser- K2 program consists of two weekly, 30-minute treatments of the LipoLaser and an additional ten minutes on the K2 full body vibration machine for four - six weeks.
Using the K2 in addition to the LipoLaser helps to enhance the oxygenation of the cells and tissues, stimulating the lymphatic system, lowering cholesterol and triglyceride levels, increasing metabolism so that you burn calories more efficiently, enhancing digestion, increasing immunity against disease and improving energy.

Lymphatic drainage

LipoLaser treatments result in the liquefaction of fats, but this fat must then be flushed from the body.
If it is not eliminated, it will simply find another resting place.

That is where the K2 full body vibration machine can help.
The lymphatic system is the body's garbage collection system. It is a vital circulatory system more extensive than the body's system of veins, and critical to managing the removal of wastes. It
contains over 600 collection sites called lymph nodes.

When the lymph system is not active, wastes begin to accumulate at the lymph nodes, which can become blocked. Aging and lack of exercise contribute to the clogging of the lymph nodes with toxins
and waste. This stagnant excess of sludge-like material, full of toxic waste, provides ideal conditions for the onset of numerous diseases, including cancer.

The best nutrition in the world cannot keep us healthy if our systems of elimination are stagnant. However, when the lymph system is activated through movement, delivery of the waste materials to the organs responsible for disposal is greatly increased.

Lymphatic circulation is absolutely essential for good health, and particularly important in any effective weight loss program.
The lymphatic system is not connected to the heart, so it depends on other mechanisms for proper circulation, all of which are stimulated by the K2 vibration machine, muscular contraction from
exercise and movement, gravitational pressure, internal massage to the valves of the lymph system and the Bowen Technique, which greatly enhances the functioning of the lymphatic system.

Source: http://healingwhatis.com/newsletter1.1.pdf

[cyba]

Meridian Co., Ltd.: LipoLaser Global Distribution Footprint Widens to Include Mexico
Wednesday November 7, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Nov 7, 2007 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that its North American distributor, Meridian Medical Inc. has signed a distribution subcontract with World Scientific Instrument (WSIM) for the marketing and sales of Meridian's LipoLaser in Mexico.

The contract stipulates that WSIM will be granted an exclusive license to market the LipoLaser throughout the Western States of Mexico including Baja California North and South, Sonora, Sinaloa, Nayarit and Jalisco. WSIM has sold high-quality medical equipment for four years and established more than 3,000 customer accounts nationwide.

The LipoLaser will join over 100 other medical-grade devices currently available from WSIM including ultrasound, radiology, CT as well as diagnostic equipment and furniture required for standard hospital treatment, emergency treatment, surgery and recovery. For WSIM, the LipoLaser presents an opportunity to expand their business into the rapidly growing aesthetics industry.

"Our partnership with Meridian for LipoLaser distribution will allow us to meet the increasing demand among our existing customers for non-surgical alternatives for inch loss and spot fat reduction," said Fernando Sanchex Soto, WSIM President and General Manager. "Based on a successful sales and marketing model for the Western States, we have plans to expand distribution of LipoLaser to include Mexico City and eventually the entire nation."

For more information about WSIM, please visit their website www.wsim.com.mx.

Source: Meridian Co., Ltd.

[cyba]

Meridian Co., Ltd. Receives Health Canada Approval for LAPEX 2000 LipoLaser-A Revolutionary New Device for Painless Fat Reduction & Body Contouring
Thursday November 15, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Nov 15, 2007 -- Meridian Co. Ltd. (OTC BB:MRDAF.OB - News) announced today that it has received regulatory approval from Health Canada to market its LAPEX 2000 LipoLaser System (LipoLaser) in Canada. The LipoLaser will be marketed in Canada for girth loss, body contouring, and the reduction in the appearance of cellulite.

"The LipoLaser's ability to deliver instant results sets it apart from the rest of the aesthetic devices available today," said Anna Brazier, President of Meridian Medical, Inc., the exclusive North American distributor for LipoLaser. "Our patent pending Body Forming Technology directly targets stubborn fat cells in a non-invasive way."

Equivalent to a United States Food and Drug Administration (FDA) clearance, Health Canada's license number assignment makes the LipoLaser available immediately for sale and use throughout all provinces and territories in Canada. Doctors or patients interested in receiving more information can call: 1-877-738-8119.

Source: Meridian Co., Ltd.

[cyba]

Meridian Medical Inc. Revolutionizes Body-Forming Technology With the LAPEX 2000 LipoLaser
Monday December 3, 2:59 pm ET

Health Canada approved LipoLaser uses innovative laser technology to instantly reduce body fat

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 3, 2007) - Meridian Medical Inc. (OTCBB:MRDAF - News)is pleased to announce the launch of the Health Canada approved LAPEX 2000 LipoLaser - a non-invasive, pain-free laser treatment for spot fat reduction and aesthetic body-forming. Using innovative laser technology, the LipoLaser targets fat tissue layers, instantly refining and reshaping problem areas including waistlines, arms, legs, thighs, buttocks and back.

LipoLaser is a stand-alone body-forming laser system, which has received Health Canada approval and is exclusively distributed by Meridian Medical Inc. in North America. "With a single treatment, LipoLaser has the ability to reduce waistlines and other areas by one to four centimetres on most skin and body types, setting it apart from any other body-forming aesthetic device on the market," said Anna Brazier, president of Meridian Medical Inc. "Doctors have reported as much as five inches of loss after a standard four week treatment cycle. The LipoLaser offers clients the luxury of inch loss without having to go under the knife."

LipoLaser uses patent and patent-pending technology to externally target fat cells during each treatment session. Treatments are completely non-invasive and pain-free, allowing clients to resume normal activities immediately after each treatment without any residual bruising, swelling or discomfort.

"Studies have shown that those who eat a healthy diet and exercise regularly will experience the best LipoLaser results. However, even those with sluggish metabolisms have reported a unique and invigorating body wake-up," said Brazier.

During treatments, the fat cells are made temporarily permeable allowing cell contents to spill out, converting the fat to free fatty acids, water and glycerol, which in turn are processed through the body's natural metabolic functions. The body can easily process the amount of mobilized fat released during a standard treatment cycle.

Low-level laser technology has been used and studied for more than 20 years for a variety of biomedical purposes including wound healing, pain relief and inflammation. Meridian Medical conducted an FDA and Health Canada-requested double-blind randomized institutional review board study on the safety and efficacy of the LipoLaser. The study concluded that LipoLaser provided a significant girth loss, which was maintained over repeated treatments.

The LipoLaser's small size and ease of portability allows trained technicians to conduct treatments in any small room with a standard electrical outlet from exam rooms to treatment rooms to the home.

Source: Meridian Medical Inc.

[cyba]

Meridian's CSA Mark Leads to Distribution Agreement With Henry Schein Ash Arcona
Tuesday December 4, 9:00 am ET
A subsidiary of Henry Schein, Inc., the Largest Distributor of Healthcare Products in North America

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Dec 4, 2007 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that it has been granted CSA's Certificate of Compliance for its Digital Pulse Analyzer (DPA). This certification is required by leading medical companies for distribution, and for hospitals and fitness centers to carry medical devices across North America.

Meridian and Henry Schein Ash Arcona ("HSAA"), the Canadian counterpart to Henry Schein, Inc., have been in negotiations for the distribution of the DPA and the CSA mark has led both companies to reach an agreement for HSAA to market, promote and distribute the Digital Pulse Analyzer throughout Canada.

About Henry Schein Ash Arcona Inc.

Henry Schein Ash Arcona is Canada's fastest growing Healthcare distributor with equipment showrooms from coast to coast, providing quality medical supplies and equipment to healthcare offices right across the country. For more information, visit the Henry Schein Ash Arcona website at http://www.hsa.ca.

Source: Meridian Co., Ltd.

[cyba]

Meridian to Attend the 15th Annual World Congress on Anti-Aging Medicine
Wednesday December 12, 3:28 pm ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Dec 12, 2007 -- Meridian Medical Inc., the exclusive North American distributors for Meridian Co., Ltd. ("Meridian") (OTC BB:MRDAF.OB - News) is pleased to announce that it will be attending the 15th Annual International Congress on Anti-Aging Medicine and Biomedical Technology, with an expected attendance of over 5,000 participants seeking innovative treatment modalities.

Joining the Meridian Medical Inc. team, will be the President and CEO of Meridian, Mr. Myeong, and the recently hired International Sales Manager, Scud Kim. "Over the last few years the Anti Aging Conference has always been a successful event for Meridian, and we welcome the opportunity to showcase our products and answer questions that the attendees may have," says Mr. Myeong.

"The anti-aging conferences have always been successful events for Meridian that have increased our sales, distribution channels and presence throughout North America."

This conference is the largest, leading industry event worldwide in the area of preventative medicine and bio-medical technologies. Anti-aging medicine is the fastest growing new medical specialty and Meridian's product line fits perfectly into this progressive environment. In attendance will be some of the most influential physicians, scientists, educators, industrialists, investment bankers and journalists from around the world.

The conference will be held at the Venetian in Las Vegas from December 13 to 15, 2007. Meridian will be demonstrating the LAPEX 2000 LipoLaser, which has recently received Health Canada approval, the Digital Pulse Analyzer, and Bp Tru at booth 3100.

Source: Meridian Co., Ltd.

[cyba]

Zapping away the fat

CARLY WEEKS
From Thursday's Globe and Mail
December 27, 2007 at 1:40 AM EST

OTTAWA — No matter what she tried, Karen Kruper always had a muffin top – the flabby skin around her waist that would stick out when she did up her jeans.

Ms. Kruper, an actress who lives in Vancouver, didn't want to undergo the painful and costly process of liposuction.

So when she heard about a new procedure that uses lasers to reduce fat without surgery, she couldn't resist. After three 10-minute sessions during clinical trials for the Lapex 2000 LipoLaser, which was recently approved for use in the country by Health Canada, Ms. Kruper said she lost about an inch from her waist.

“It was pretty remarkable,” she said. “There's no painkillers required, there's absolutely no downtime.”
How liposuction works



Ms. Kruper is one of many Canadians opting for new procedures that use lasers to target fat in order to avoid traditional liposuction, which can require a significant investment and extensive recovery period.

But some plastic surgeons question whether laser treatments produce worthwhile results, especially considering some, including the LipoLaser procedure, don't even remove fat from the body.

“I'm skeptical that it would work as well as they say it does because liposuction isn't just removing the fat, it's sculpting” – a process where doctors mould skin from the inside to appear firm and toned as they vacuum out the fat – said Lorne Tarshis, chief surgeon at the Institute of Cosmetic Surgery in Toronto.

Meridian Medical Inc., which makes the LipoLaser, touts the treatment as a non-invasive and pain-free way to reduce body fat. However, the company also says the procedure is meant for “spot fat reduction” and that clients shouldn't expect dramatic results. Patients can expect to lose one to four centimetres after a treatment, which costs $150 to $200.

“You can have fairly significant loss when incorporated with diet and lifestyle,” said Jonas LaForge, a naturopathic physician and Meridian Medical's director of medical and technical sales.

The LipoLaser procedure works by placing paddles on the patient's desired problem area so lasers can target and break up fat cells into fatty acids, water and glycerol that are either used by the body or flushed out.

It's the second laser-based liposuction procedure to be approved in Canada in the past six months as the cosmetic surgery industry seeks to cater to clients such as Ms. Kruper who don't want to experience the trauma of surgery in order to trim down.

“I didn't want to go through liposuction,” Ms. Kruper said. “To me there's no comparison between surgery and lasering.”

In the United States, the LipoLaser is awaiting approval by the Food and Drug Administration.

Unlike the LipoLaser, the Smartlipo treatment, approved for use in Canada earlier this year, uses lasers to liquefy fat cells that are later vacuumed out of the body with a cannula.

The American Society of Plastic Surgeons said that 9.1 million minimally invasive plastic surgeries on all areas of the body were conducted in 2006, an increase of 66 per cent from 2000.

Controversy over liposuction erupted in September when a Toronto woman died after undergoing a procedure. The case highlighted concerns in Canada over family doctors who perform cosmetic surgery without the proper qualifications.

Claudio De Lorenzi, former president of the Canadian Society for Aesthetic (Cosmetic) Plastic Surgery, said he does not use laser fat-reduction treatments at his Kitchener, Ont., clinic because they don't seem to offer any advantages over traditional treatments.

“Apart from some slight reduction in bruising, there's really no major benefit from it,” Dr. De Lorenzi said.

To some in the industry, this new crop of laser fat-reduction treatments seems to be a response to the growing demand for pain-free procedures that may simply be ineffective.

“There's a whole trend around trying to get surgical results without surgery,” Dr. Tarshis said. “I think it's possible with liposuction, but I don't think we're there yet.”

Ms. Kruper said the laser treatments worked for her and helped eliminate pockets of fat she's been unable to get rid of for years.

“I'm all over it,” she said. “I just have to cite my own case.”

http://www.theglobeandmail.com/servlet/story/RTGAM.20071227.…

[cyba]

Meridian Co., Ltd.: Lapex 2000 LipoLaser Global Distribution Now Includes the Persian Gulf
Wednesday January 9, 9:00 am ET

Not Just a body contouring system but a "Lifestyle" changing experience

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jan 9, 2008 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that they have signed an exclusive distribution agreement for the Persian Gulf with Laser Lipo (Dubai) Ltd. ("Laser Lipo").

The contract outlines that Laser Lipo will be granted an exclusive license to market the LAPEX 2000 BCS ("BCS") in the Persian Gulf, focusing primarily in Dubai. Their exclusive distributorship for the BCS is based on a minimum order volume equal to sales of approximately US $16 million for the three year term of the contract.

The Lipo Laser is "not just a body contouring system, in some cases, it can be a lifestyle changing experience. We look forward to introducing the BCS in to the gulf region, which has one of the highest percentages of wealth in the world," says Ian Cobley, Director of Laser Lipo Ltd.

"Laser Lipo plans on distributing the BCS through their affiliate company, CPL International LLC in the Gulf region and directly in the UK. We feel confident that we can surpass our anticipated sales of over 2 million in the initial 12 months from our UK launch," says Sharon Cobley, Director of Laser Lipo Ltd. She continues; "Our knowledge and connections with leading European cosmetic surgeons, coupled with our experience in the aesthetic arena, assures us that this technology is just what the whole industry has been waiting for- a risk free alternative to invasive procedures such as liposuction."

More about: Laser Lipo Ltd.

Laser Lipo is a privately owned company based in the UK with offices in Dubai. The management team has many years of experience at the top end of the beauty industry, including semi permanent make-up, Microdermabrasion, Botox®, facial line fillers, Laser hair removal and medical skin peels.

Source: Meridian Co., Ltd.

[dj_Investor]

Antwort auf Beitrag Nr.: 32.996.669 von cyba am 09.01.08 18:22:51

dj

[cyba]

Antwort auf Beitrag Nr.: 33.035.130 von dj_Investor am 13.01.08 19:51:39

[cyba]

Meridian's UK connection:

http://laserlipo-bcs.com/

[cyba]

Meridian Hires International Sales Manager
Wednesday February 20, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Feb 20, 2008 -- Meridian Co., Ltd. (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that John Y.C. Myoung has joined the company as International Sales Director. Due to continued rapid growth in international sales, Mr. Myoung will be responsible for world wide distribution of all of Meridian's products.

Mr. Myoung has 20 years of marketing and sales experience and has held account management positions at electronic and medical device companies in Korea including LG Electronics Co., Ltd. and Medison Co., Ltd. where he served as a Director of International Sales. During his time at Medison, Myoung contributed to the significant growth of sales in international markets and saw an increase of oversea sales from US $20 million to $70 million. Myoung has strong experience selling to international markets and will play an instrumental role in helping Meridian expand globally.

"We are excited to have John Myoung as part of our sales team," said Mr. Meyong, company president. "Because of his previous sales experience, we are certain that John will serve as a real asset to our company. Meridian understands the importance of customer service and believes John will contribute significantly with our international customers."

Mr. Meyong and Mr. Myoung will be visiting Meridian Medical Inc. (MMI), the North American Distributor of Meridian Products, February 24-29th. During this time, this will assist MMI in launching the Lapex 2000 LipoLaser to the Canadian market at the Esthetique Spa International Trade Show that will be held in Vancouver February 24th and 25th.

Source: Meridian Co., Ltd.

[cyba]

Meridian Co., Ltd.: LipoLaser Global Distribution Expands to Include Turkey
Wednesday February 27, 1:51 pm ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Feb 27, 2008 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment is pleased to announce that they have signed an exclusive distribution agreement with Ozkaya Ithalat and Modem Co. ("Modem"), a company based in Turkey.

The contract outlines that Modem will be granted an exclusive license to market the LAPEX BCS in Turkey. Their exclusive distributorship for the LAPEX BCS is based on a minimum order volume equal to sales of approximately US $2.5 million for the first two years of the contract.

"Modem is a major player in the rapidly growing Turkish aesthetic market," said recently appointed International Sales Director for Meridian Co., John Myoung. "They are ideally situated to distribute LAPEX BCS in the country, initially focusing on both Istanbul and Ankara, and continuing to expand throughout Turkey." Modem is very familiar with the aesthetic market as they are currently distributing the Power Plate Whole Body Vibration Platform to spas and wellness centers.

Source: Meridian Co., Ltd.

[cyba]

http://www.scribd.com/doc/2182367/8-page-March-mail-out02272…

[cyba]

Meridian Co., Ltd. to Introduce New Lapex 2000 LipoLaser to Canadian Media and Marketplace in Eastern Canada
Wednesday March 5, 9:00 am ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Mar 5, 2008 -- Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that it's North American Exclusive Distributor, Meridian Medical Inc., (MMI) will be launching the Lapex 2000 LipoLaser to Eastern Canada this weekend at the International Anti-Aging Show (IAAS) to be held March 7-8-9 at Toronto's International Centre.

The (IAAS) features over 100 exhibitors and sponsors highlighting the latest in the world of anti-aging. The IAAS is the only show of its kind in Canada, 100% dedicated to the anti-aging industry. Meridian will be at Booth 410 featuring the Lapex 2000 LipoLaser, the Digital Pulse Analyzer and the BP Tru.

The Lapex 2000 LipoLaser continues to receive positive media attention in Eastern Canada. Meridian will be featured on Breakfast Television where they will perform a live LipoLaser treatment from their tradeshow booth on Friday, March 7th. Breakfast Television is a Canadian morning news and entertainment program which airs on CityTV Toronto each morning from 6:00am-9:00am EST.

In addition, the CH Live Morning Show will be taping a live LipoLaser treatment on their Thursday morning show which airs from 6:00am-9:00am EST. The CH Live Morning Show broadcasts throughout most of Ontario. Some cable systems outside of Ontario also carry CH including Buffalo, Philadelphia, and Western New York.

The Meridian Team welcomes your questions about the LAPEX 2000 LipoLaser. For more information about the product, please visit www.meridianmedical.ca or contact us at [e-mail] to arrange for a web-based presentation.

Source: Meridian Co., Ltd.

[cyba]

Meridian Co., Ltd. Corporate Update
Thursday , April 10, 2008 18:14ET

VANCOUVER, BRITISH COLUMBIA, Apr 10, 2008 (Marketwire via COMTEX) -- Meridian Co., Ltd. (OTCBB:MRDAF) is engaged in the research, development, manufacturing and sales of advanced medical equipment. Meridian would like to take this opportunity to provide a corporate update and to thank its customers and shareholders for their unwavering support and commitment to Meridian over the past several years.

As part of Meridian's continued commitment to global expansion we are proud to introduce a new team member, Dr. Jonas LaForge. He is trained and certified in the use of aesthetic laser technologies for the purpose of body contouring and inch loss. Dr. Jonas LaForge currently holds the position of Director of Medical and Technical Sales at Meridian Medical Inc. His extensive leadership in anti-aging and aesthetic medicine, his experience in aesthetic training, and his knowledge and enthusiasm of the aesthetic market combine to make him uniquely qualified to lead the Lapex-2000 LipoLaser division of Meridian. Dr. LaForge will be travelling to Mexico next week to meet with Meridian's distributor, World Scientific Instrument with the purpose of training over 20 physicians on the use of low-level laser for body contouring.

The Company is moving forward at an exciting pace as it has achieved major milestones over the past year and looks forward to continued expansion as it implements its global strategy for 2008 and 2009.

Lapex-2000 LipoLaser / Lapex BCS ("Body Contouring System")

In 2007, Meridian received regulatory approval from both the European Union (CE) and Health Canada for the Lapex-2000 LipoLaser - Meridian's innovative low-level laser body contouring device. Meridian has taken this important milestone in its product development to further expand the LipoLaser launch worldwide. Currently, the Company has established a strong foothold in the United Kingdom, Canada, France, Turkey, the Persian Gulf and Asia along with continued interest from many other EU countries. In this regards, Mr. John Myoung, Meridian's International Sales Director, will be meeting with several large, well-known European medical distributors while attending the "COSMO PROF" international tradeshow in Bologna, Italy later this month. Based on current sales leads, Mr. Myoung, expects to close sales contracts with companies operating in Sweden, Italy, Spain and possibly Germany at that time.

Meridian would like this chance to address the unexpected delays of FDA 510 (k) clearance for the LipoLaser in the United States. Meridian has retained the most highly regarded FDA legal and procedural consultants available to ensure a satisfactory conclusion within a reasonably acceptable time frame. There were some unexpected delays due to the uniqueness of the indication for use. Based on confidence shown by other International Regulatory Bodies, including European Economics Community Clearance (CE) and Health Canada, combined with a prompt response to all queries from the FDA, we look forward to updating our shareholders with favorable results in the very near future.

In anticipation of final FDA approval, Meridian has already begun to establish important sales and distribution leads in the United States and has developed plans to launch an aggressive campaign and fulfill pending orders.

Digital Pulse Analyzer (DPA)

Meridian Co., Ltd. has recently signed a supply contract with HanLim Pharmaceutic Company to supply DPA to pharmacy chains throughout Korea and is actively pursuing strong interest from within the European Union. In May 2008, John Myoung, Meridian's International Sales Director, will be travelling to Portugal to meet with several large, well-known European medical distributors while attending an international anti-aging conference. Meridian is expecting this to coincide with the issuance of the CE/MDD approval for this device allowing for further expansion throughout the European Union.

Meridian's Manufacturing Operation and Supply Chain

Meridian has made significant improvements to its entire manufacturing operation to enable seamless delivery to its worldwide client base. The Company has secured contracts with all of its suppliers and vendors to ensure timely delivery of materials. Updated software and inventory systems have been installed to ensure maximum client value and service.

Meridian in the Media

The company continues to gain both media and investment interest for its non-invasive technologies that will drive sales and increase revenue. Meridian's anticipated revenue projections for 2008 are anticipated to be US$22 million.

On Behalf of the Board of Directors,

Hyeon Seong Meyong, President


SOURCE: Meridian Co., Ltd.